Product Information

ZAFIRLUKAST 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5295 per EA under NDC 59651029160. Its NADAC has been published 111 times since Jul 10, 2024.

FDA first approved this application on Nov 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZAFIRLUKAST 10 MG TABLET

Zafirlukast
$0.5295per EA

Strength

10 mg/1

NDC

59651029160

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

Generic (ANDA)

FDA Application

ANDA213163

FDA Approved

11/27/2023

TE Code

AB

On Market Since

11/27/2023

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for ZAFIRLUKAST 10 MG TABLET has been published 111 times since Jul 10, 2024, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5295 per EA
All-time high$0.7093 (Oct 16, 2024)
All-time low$0.4056 (Feb 19, 2025)
52-week high$0.6284
52-week low$0.5023
Median price$0.5372
Average price$0.5575
Largest weekly change-23.1% (Nov 20, 2024)
Weeks tracked111
Tracking sinceJul 10, 2024

Price History

1W

-1.7%

1M

-1.7%

3M

+3.1%

6M

+0.6%

1Y

-15.7%

3Y

N/A

5Y

N/A

All

-14.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZAFIRLUKAST 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.5295 per EA (NDC 59651029160), effective Aug 19, 2026.

How has the price of ZAFIRLUKAST 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZAFIRLUKAST 10 MG TABLET has declined 14.1%. It has been tracked across 111 weekly CMS publications since Jul 10, 2024.

What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 10 MG TABLET?

Since Jul 10, 2024, the NADAC for ZAFIRLUKAST 10 MG TABLET has ranged from a low of $0.4056 (Feb 19, 2025) to a high of $0.7093 (Oct 16, 2024), with a median of $0.5372 per EA.

Are there cheaper alternatives to ZAFIRLUKAST 10 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZAFIRLUKAST 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZAFIRLUKAST 10 MG TABLET?

ZAFIRLUKAST 10 MG TABLET (NDC 59651029160) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.